From Headache to Hemodialysis: Undiagnosed HIV Presenting as APOL1-Associated Collapsing Glomerulopathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0724; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Hemodialysis was initiated on day 7 followed by ART therapy on day 8 (dolutegravir and TDF/emtricitabine). Viral suppression may mitigate APOL1-associated kidney decline, though patients with advanced disease often remain dialysis-dependent. Kidney biopsy is essential for diagnosis, and APOL1 genotyping provides prognostic value and may identify candidates for emerging targeted therapies such as inaxaplin."
Chronic Kidney Disease • Glomerulonephritis • Hematological Disorders • Human Immunodeficiency Virus • Infectious Disease • Renal Disease • CD4
|
|
Marc H. Isidor; Sabbir Mirza; Donald Orji Kanu; Rahil Khan
|